| A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand R Ragupathy, K Aaltonen, J Tordoff, P Norris, D Reith Pharmacoeconomics 30, 1051-1065, 2012 | 50 | 2012 |
| The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand K Aaltonen, R Ragupathy, J Tordoff, D Reith, P Norris Value in Health 13 (1), 148-156, 2010 | 37 | 2010 |
| KEY INFORMANTS’PERCEPTIONS OF HOW PHARMAC OPERATES IN NEW ZEALAND R Ragupathy, J Tordoff, P Norris, D Reith International journal of technology assessment in health care 28 (4), 367-373, 2012 | 19 | 2012 |
| Pharmaceutical pricing in New Zealand R Ragupathy, K Kilpatrick, ZUD Babar Pharmaceutical prices in the 21st century, 189-207, 2014 | 12 | 2014 |
| Access to children’s medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007 R Ragupathy, J Tordoff, P Norris, D Reith Pharmacy world & science 32, 386-393, 2010 | 12 | 2010 |
| Exploring pharmacists' opinions regarding PHARMAC's interventions in promoting brand changes ZU Babar, A Polwin, SW Kan, N Amerasinghe, S McCarthy, F Rasheed, ... Research in Social and Administrative Pharmacy 11 (1), 96-110, 2015 | 10 | 2015 |
| Coverage and accuracy of ethnicity data on three Asian ethnic groups in New Zealand P Norris, S Horsburgh, P Padukkage, NY Baik, D Kim, A Fussell, ... Australian and New Zealand journal of public health 34 (3), 258-261, 2010 | 9 | 2010 |
| Applying the Reason Model to enhance health record research in the age of'big data'. R Ragupathy, V Yogarajan | 6 | 2018 |
| New Zealanders’ access to licensed and subsidised medicines compared with a nationwide single payer system in each of Australia, the United Kingdom and the United States Y Ragupathy University of Otago, 2013 | 6 | 2013 |
| Comparing the reimbursement of new medicines between Australia and New Zealand R Ragupathy Australian Health Review 40 (1), 118-119, 2015 | 3 | 2015 |
| Prostate cancer screening and ethical use of limited resources R Ragupathy, DB Menkes The New Zealand Medical Journal (Online) 126 (1385), 2013 | 2 | 2013 |
| Randomized controlled phase II trial of simvastatin as prophylaxis against radiation-induced skin toxicity in breast cancer patients. S Joseph, G Round, MB Jameson, JM Boyd, R Ragupathy Journal of Clinical Oncology 31 (15_suppl), TPS1143-TPS1143, 2013 | 2 | 2013 |
| Research using electronic health records: not all de-identified datasets are created equal V Yogarajan, R Ragupathy CSIRO Publishing 11 (1), 14-15, 2019 | 1 | 2019 |
| Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity R Ragupathy, M Jameson The New Zealand Medical Journal (Online) 129 (1440), 22, 2016 | 1 | 2016 |
| Defence of the Living Dead: zombies as vectors for transmitting positive health messages R Ragupathy The New Zealand Medical Journal (Online) 129 (1435), 95, 2016 | 1 | 2016 |
| New Zealand consumers’ perceptions of private insurance for pharmaceuticals R Ragupathy, ZD Babar, W Mirza, M Daiya, H Chandra, A Yousif, M Girn SpringerPlus 3, 1-6, 2014 | 1 | 2014 |
| PHP14 THE EFFECTS OF PHARMACEUTICAL COST CONTAINMENT ON ACCESS TO LICENSED AND SUBSIDIZED MEDICINES UNDER SINGLE PAYER SYSTEMS IN THE UNITED STATES, UNITED KINGDOM, AUSTRALIA … R Ragupathy, K Aaltonen, J Tordoff, P Norris, D Reith Value in Health 14 (3), A14, 2011 | 1 | 2011 |
| A pilot randomised controlled trial of oral doxycycline after endoscopic sinus surgery and its effects on the sinonasal microbiome JM Challis, MS Baptista, R Ragupathy, CKW Lee, AJ Wood European Rhinologic Society 4 (4), 49-61, 2022 | | 2022 |
| Health information research privacy standards should include Māori perspectives on privacy R Ragupathy, V Yogarajan, C Luoni New Zealand Medical Association 132 (1494), 64-67, 2019 | | 2019 |
| Adoption of international privacy standards in New Zealand health information research. V Yogarajan, R Ragupathy | | 2019 |
